Search
Vonoprazan
go.drugbank.com/drugs/DB11739ApprovedInvestigationalUnlike proton-pump inhibitors, PCABs are not affected by CYP2C19 genetic polymorphisms and do not require acid-resistant formulations.
Isavuconazonium
go.drugbank.com/drugs/DB06636ApprovedInvestigationalDue to low solubility in water of isavuconazole on its own, the isovuconazonium formulation is favorable as it has high solubility in water and allows for intravenous administration.
Fomivirsen
go.drugbank.com/drugs/DB06759ApprovedWithdrawnThe drug was withdrawn by the FDA because while there was a high unmet need for drugs to treat CMV when the drug was initially discovered and developed due to the CMV arising in people with AIDS, the development
Histrelin
go.drugbank.com/drugs/DB06788ApprovedInvestigationalWithdrawn[L41710] GnRH agonists are the first line of treatment for children with central precocious puberty (CPP) due to their capacity to reduce LH levels and the concentration of sex steroids.
Synonyms: [(im-Bzl)-D-His6,Pro9-NEt]-gonadotropin releasing hormone, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-1-benzyl-D-histidyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamideSodium oxybate
go.drugbank.com/drugs/DB09072ApprovedInvestigational[A251430] Due to its physiological effects, sodium oxybate is associated with a risk for substance misuse and abuse.
Ancitabine
go.drugbank.com/drugs/DB20595ExperimentalAncitabine has a monoisotopic molecular weight of 225.07 Da.
Galocitabine
go.drugbank.com/drugs/DB21373ExperimentalGalocitabine has a monoisotopic molecular weight of 439.14 Da.
Alpibectir
go.drugbank.com/drugs/DB21561InvestigationalAlpibectir has a monoisotopic molecular weight of 332.1 Da.
Ceperognastat
go.drugbank.com/drugs/DB21591InvestigationalCeperognastat has a monoisotopic molecular weight of 383.14 Da.
Ranosidenib
go.drugbank.com/drugs/DB21727InvestigationalRanosidenib has a monoisotopic molecular weight of 453.12 Da.